Bryan JM, Beyene T, Kebede S, Kaufman A, Jiru T, Maskalyk J, Landes M, McKnight A, Fremes E, Cheung E, Toronto Addis Ababa Academic Collaboration in Emergency Medicine. (2021). Maintaining a global health partnership during the COVID-19 pandemic: a road map from the Toronto Addis Ababa Academic Collaboration in Emergency Medicine, 23(2): 242-244. doi:10.1007/s43678-021-00083-1.

Joel L, Graham J, Herder M, Jefferson T, Lemmens T. (2021). Regulators, Pivotal Clinical Trials, and Drug Regulations in the Age of COVID-19. International Journal of Health Services, 51(1): 5-13. doi:10.1177/0020731420979824

Hohl C, Bosychuk R, McRae A, Brooks S, Archambault P, Fok P, Davis P, Landes M...Morrison L. (2021). Development of the Canadian COVID-19 Emergency Department Rapid Reponse Network population-based registry: a methodology study. CMAJ Open, 9 (1). doi: 10.9778/cmajo.20200290

Landes M, van Lettow M, van Oosterhout J, Schouten E, Auld A, Kalua T, Jahn A, Barr BT. (2021). Early post-partum viremia predicts long-term non-suppression of viral load in HIV-positive women on ART in Malawi: Implications for the elimination of infant transmission. Plos One, 16 (3). doi: 10.1371/journal.pone.0248559.

Lexchin J. (2021). Time to marketing of generic drugs after patent expiration in Canada. JAMA Network Open; 4(3): e211143.  doi:10.1001/jamanetworkopen.2021.1143

Habibi R, Lexchin J. The COVID-19 vaccination race: why wealthy countries like Canada must do more to help poorer ones get across the finish line. Open Canada. March 9, 2021.  

Ben-Yakov M & James V. (2021). Young man with a diffuse rash and red eyes after recovery from COVID-2019. JACEP Open, 2(2). doi:10.1002/emp2.12404

Lexchin J, Bero LA, Davis C, Gagnon MA. (2021). Commercial influence in health: from transparency to independence. BMJ; 372. doi:/10.1136/bmj.n370 

Ben-Yakov M, Price C, Dharamsi A, Tawadrous D, Choi JM. (2021). Intubator performance and contamination with the use of barrier enclosure devices: Results from a simulated COVID-19 resuscitation. Annals of Work Exposures and Health. doi:10.1093/annweh/wxaa144

Benham JL, Lang R, Bruns KK, MacKean G, Leveille T, McCormack B, Sheikh H...Marshall D. (2021). Attitudes, current behaviors and barriers to public health measures that reduce COVID-19 transmission: A qualitative study to inform public health messaging. PloS one, 16(2), e0246941. doi: 10.1371/journal.pone.0246941


Formosa EA, Kishimoto V, Orchanian-Cheff A, Hayman K. (2020). Emergency department interventions for homelessness: a systematic review. Canadian Journal of Emergency Medicine, 1-12. doi:10.1007/s43678-020-00008-4

Kirubarajan A, Khan S, Got T, Yau M, Bryan JM, Friedman SM. Mask shortage during epidemics and pandemics: a scoping review of interventions to overcome limited supply. BMJ Open, 2020; 10(11): 1-25. doi:10.1136/bmjopen-2020-040547 

Loutet MG, Zhang J, Varsaneux O, Ferguson A, Hulme J, Stone S, Oldenburger D, Piggott T. (2020). Using Experiential Simulation-Based Learning to Increase Engagement in Global Health Education: an Evaluation of Self-reported Participant Experience. Medical Science Educator. 30, 1245-1253. doi:10.1007/s40670-020-00999-w

Lexchin J. Would pharmacare spell trouble for drug companies? Canadian Centre for Policy Alternatives, August 5, 2020. View article here: []

Kim D, Jelic T, Woo M, Heslop C, Olszynski P. (2020). Just the Facts: Recommendations on point-of-care ultrasound use and machine infection control during the coronavirus disease 2019 pandemic. CJEM, 22(4), 445-449. doi:10.1017/cem.2020.364

Hoyeck P, Wiercigroch D, Clarke C, Moineddin R, Sheikh H, Hulme J. (2020). Understanding current practice of opioid use disorder management in emergency departments across Canada: A cross-sectional study. CJEM, 22(4), 494-498. doi:10.1017/cem.2020.362

McLaren J, Hayman K, Sheikh H. (2020). CAEP Position Statement – Sick notes for minor illness. CJEM, 22(4), 475-476. doi:10.1017/cem.2020.53

Tawadrous D, Doran S, Davis M. (2020). Use of a smartphone plant identification application in a toxic plant ingestion. CJEM, 22(4), 549-551. doi:10.1017/cem.2020.30

Perry LT, Bhasale A, Fabbri A, Lexchin J, Puil L, Joarder M, Mintzes, B. A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016. Pharmacoepidemiology and Drug Safety 2020. doi:10.1002/pds.5072

Jarvis J, Lexchin J. WHO’s COVID-19 technology access pool deserves Canada’s support. Policy Options July 14, 2020. Available at:

Lexchin J. COVID-19: still much to learn. Journal of the Royal Society of Medicine 2020;113(7):244. doi: 10.1177/0141076820932878

Wright JK, Tan DH, Walmsley SL, Hulme J, O’Connor E, Snider C, Cheng I, Chan AK, Borgundvaag B, McLeod S, Gollob MH, Clarke RJ, Dresser L, Haji F, Mazzulli  T, Mubareka S, Jüni P, Lee D, Tomlinson G, Kain K, Landes, M. (2020). Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada. Trials, 21(1), 1-3. doi:10.1186/s13063-020-04577-8

Dharamsi A, Hayman K, Yi S, Chow R, Yee C, Gaylord E, Tawadrous D, Chartier LB, Landes M. (2020). Enhancing departmental preparedness for COVID-19 using rapid cycle in situ simulation. Journal of Hospital Infection. 105(4), 604-607. doi: 10.1016/j.jhin.2020.06.020.

Dion D, Mosleh-Shirazi, Lexchin J. Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study. BMJ Open 2020;10:e034993. doi:10.1136/ bmjopen-2019-034993. 

Bhayana R, Wang CD, Menezes RJ, Bartlett ES, Choi J. (2020). Optimising after-hours workflow of computed tomography orders in the emergency department. BMJ open quality, 9(3), e000969.

Hansen K, Boyle A, Holroyd B, Phillips G, Benger J, Chartier LB, Lecky F, Vaillancourt S, Cameron P, Waligora G, Kurland L, Truesdale M, on behalf of the IFEM Quality and Safety Special Interest Group (2020). Updated framework on quality and safety in emergency medicine. Emergency Medicine Journal 2020;37:437-442.

Friedman N, Scolnik D, McMurray L, Bryan J. (2020). Acquired methemoglobinemia presenting to the pediatric emergency department: a clinical challenge. Canadian Journal of Emergency Medicine, 1-5. 

Barth D, Nemec RM, Cho DD, Slomer A, Cojocari E, Kim K, McLean L, Patriquin CJ. (2020). The practical integration of a hybrid model of ultrasound‐guided peripheral venous access in a large apheresis center. Journal of Clinical Apheresis.

Lexchin J. (2020). "As U.S. buys up remdesivir, ‘vaccine nationalism’ threatens access to COVID-19 treatments".

Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ, 2020; 369:m1505.

Lexchin J. Key opinion leaders and the control of knowledge. In: Allen DM, Howell JWeds. Groupthink in science: greed, pathological altruism, ideology, competition, and culture. Springer, 2020; 143-152. 

James R, Lexchin J. After COVID-19’s tragic roll, Canada must improve quality of life in long-term care homes. The Conversation. June 7, 2020. Available at:

Elder K, Turner KA, Cosgrove L, Lexchin J, Shnier A, Moore A, Straus S, Thombs BD. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study. CMAJ, 2020; 192:E617-E625. doi: 

Sanford S, Schwartz B, Khan Y. The role of tacit knowledge in communication and decision-making during emerging public health incidents. International Journal of Disaster Risk Reduction, 2020; 101681. doi:

Aubry T, Bloch G, Brcic V, Saad A, Magwood O, Abdalla T, Alkhateeb Q, Xie E, Mathew C, Hannigan T, Costello C, Thavorn K, Stergiopoulos V, Tugwell P, Pottie E. Effectiveness of permanent supportive housing and income assistance interventions for homeless individuals in high-income countries: a systematic review. The Lancet Public Health, 2020; 5(6): e342-e360. doi:

Lexchin J. Drug Promotion in India Since 2000: Problems Remain. International Journal of Health Services, 2020; doi:

Lexchin J. Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study. International Journal of Health Policy and Management, 2020; doi:10.34172/ijhpm.2020.100 

Lexchin J. Health Canada's Proposal to Accelerate New Drug Reviews. Healthcare Policy, 2020; 15(4), 26-34. doi:10.12927/hcpol.2020.26227

Friedman SM, Porplycia D. STAR-EM: An innovative summer research program for medical students. CJEM, 2020; 1-4. doi:10.1017/cem.2020.366

Wiercigroch D, Ben-Yakov M, Friedman SM. Regional anesthesia in Canadian emergency departments: emergency physician practices, perspectives and barriers to use. CJEM, 2020; 1-5. doi:10.1017/cem.2020.51

Turner K, Carboni-Jiménez A, Benea C, Katharine E, Levis B, Boruff J, Roseman M, Bero L, Lexchin J, Turner EH, Benedetti A, Thombs BD. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. BMJ Open, 2020; 10(5), e035633. doi:10.1136/bmjopen-2019-035633

Woolner V, Ahluwalia R, Lum H, Beane K, Avelino J, Chartier LB. Improving timely analgesia administration for musculoskeletal pain in the emergency department. BMJ Open Quality, 2020; 9(1), e000797. doi:10.1136/bmjoq-2019-000797

Ostrow O, Shim A, Azmat S, Zelinka A, Masood S, Chartier, LB. Pediatric Emergency Department Return Visits: An Innovative and Systematic Approach to Promote Quality Improvement and Patient Safety. Pediatr Emerg Care, 2020; [Epub ahead of print]. PMID: 31977769. doi:10.1097/PEC.0000000000001999

Thull-Freedman, J, Mondoux, S, Stang, A, Chartier LB. Going to the COVID-19 Gemba: Using observation and high reliability strategies to achieve safety in a time of crisis. CJEM, 2020; 1-4. doi:10.1017/cem.2020.380

Mondoux S, Thull-Freedman J, Dowling S, Gardner K, Taher A, Gupta R, Trivedi S, Lindsay H, Finlayson A, Berthelot S, Kwok E,  Chartier LB. Quality improvement in the time of COVID-19 – a change strategy well suited to pandemic response. CJEM, 2020; 1-4. doi:10.1017/cem.2020.386

Nolan B, Chartier LB, Verbeek P, Huyer D, Mazurik L. Recommendations for emergency departments receiving patients with vital signs absent from paramedics during COVID-19. CJEM, 2020; 1-5. doi:10.1017/cem.2020.389

Lexchin J. Affordable Biologics for All. JAMA Netw Open. 2020;3(4):e204753. doi:10.1001/jamanetworkopen.2020.4753

Hendin A, La Rivière, CG, Williscroft DM, O'Connor E, Hughes J, Fischer LM. End-of-life care in the Emergency Department for the patient imminently dying of a highly transmissible acute respiratory infection (such as COVID-19). CJEM, 2020; 1-5. doi:10.1017/cem.2020.352

Lexchin J, Rasmussen N. The rise and fall of the neurotic housewife: patient sex in psychotropic drug advertising to physicians 1946-1990. International Journal of Health Services 2020: DOI: 10.1177/0020731420912999

Benea C, Turner KA, Roseman M, Bero LA, Lexchin J, Turner EH, Thombs BD. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009. Systematic Reviews 2020;9:77

Hobday K, Zwi AB, Homer C, Kirkham R, Hulme J, Wate PZ, Prata N. Misoprostol for the prevention of post-partum haemorrhage in Mozambique: an analysis of the interface between human rights, maternal health and development. BMC International Health and Human Rights. 2020; 20(1):1-3. 

Lexchin J, Mintzes B. Opioid marketing to Canadian doctors hyped benefits, downplayed harms. The Conversation. March 10, 2020. Available at:

Lexchin J. Canada’s coronavirus aid package guards against drug shortages with compulsory licensing. The Conversation. March 30, 2020. Available at: